Angel and Venture Capital

Nadathur's history is centered primarily on identifying entrepreneurs and backing their ventures in areas of specific interest to us. We continue to support the development of the entrepreneurial ecosystem through the N.S. Raghavan Centre for Entrepreneurial Learning (NSRCEL), an incubation unit in partnership with IIM Bangalore. Over the years we have nurtured ventures across the technology, life sciences, engineering services, media and advertising, apparel, and agriculture sectors. We deploy our venture capital via direct investments, Fund models (Ojas Venture Partners), and platform (Healthcare and Life sciences)

Click below to know more:

  Fund Models ( Tech / Tech enabled Business )

Ojas Venture Partners

Incorporating lessons learnt through the years from investing in start-ups, as well as leveraging NSR’s (as N.S. Raghavan is popularly known) experiences, we set up Ojas in 2007.  The firm focuses on investing in India-centric seed and early stage technology companies. To incorporate best practices, and institutionalize our investing model, we have brought together a professional team recruited from across the U.S., Europe and India. Further, to complement the above, we have put together a network of industry veterans who can offer advisory support to the companies.

The Ojas portfolio of companies includes start-ups that are creating new technologies (with significant intellectual property) as well as those that are using technology to offer a service. The portfolio today spans the domains of telecommunications, banking, consumer Internet and mobile, semiconductor and services. Ventures include CoCubes, India's only online end-to-end campus engagements & recruitment platform, Vizury, and internet marketing company using a proprietary behavioural targeting and dynamic creative technology, BrizzTV, a data channel provider for television networks, and TeliBrahma, a targeted advertisement, lead generation and marketing platform using mobile channels.


  Platform ( Health Care and Life Science )

In 2005, to focus on human health related opportunities, we carved out of our portfolio a specialized domain-specific platform in health care and life sciences. Thus far, we have invested through this platform into ventures that target not only the supply side (R&D) but also the demand side (health care) of the value chain. Our portfolio ranges from agri-biotech and drug discovery to health care services and hospitals.

Ventures supported by the platform that translate R&D to the marketplace include Connexios Life Sciences, a drug discovery company, and Metahelix, an agri-biotech company. We also support ventures that leverage domain expertise and unique delivery models to provide services/solutions to the local and global markets. These include Indegene Life Systems, a marketing and commercialization solutions provider to global Pharmaceutical industry, and Medi Assist a Third Party Administrator (TPA) of Health Insurance, and health care services provider.

Additionally, we set up Group Lifespring in 2007 to provide specialize advisory services in support of this platform especially on Human Health related sectors. In this pursuit, we have brought together a group of people with the requisite domain expertise, investment experience, and industry knowledge.